- Home
- QUBT vs LNTH Comparison
QUBT vs LNTH Comparison
Compare QUBT & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QUBT | LNTH |
|---|---|---|
| Founded | 2001 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.8B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | QUBT | LNTH |
|---|---|---|
| Price | $11.03 | $59.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $23.67 | ★ $74.17 |
| AVG Volume (30 Days) | ★ 28.7M | 1.3M |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.39 |
| Revenue | $546,000.00 | ★ $1,525,933,000.00 |
| Revenue This Year | $11.21 | N/A |
| Revenue Next Year | $412.29 | $1.98 |
| P/E Ratio | ★ N/A | $24.70 |
| Revenue Growth | ★ 41.45 | 1.95 |
| 52 Week Low | $4.37 | $47.25 |
| 52 Week High | $27.15 | $111.29 |
Technical Indicators
Market Signals| Indicator | QUBT | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 39.92 | 62.09 |
| Support Level | $9.50 | $51.84 |
| Resistance Level | $11.98 | $59.30 |
| Average True Range (ATR) | 1.15 | 2.10 |
| MACD | 0.21 | 0.65 |
| Stochastic Oscillator | 40.76 | 96.57 |
Price Performance
Historical ComparisonAbout QUBT Quantum Computing Inc.
Quantum Computing Inc is an integrated photonics and quantum optics technology company that provides accessible and affordable quantum machines to the world today. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offer capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.